Uganda, May 6 -- Ugandan researchers and health officials have revealed ongoing plans to introduce long-acting injectable antiretroviral therapy (ART) that can replace daily pills with injections every two months for people living with HIV/Aids.

The researchers indicated that this revolutionary treatment (cabotegravir + rilpivirine) aims to ease the burden of lifelong HIV medication adherence, reduce Aids-related deaths and address disease spread through optimised viral load suppression.

Dr Robert Mutumba, the head of the Aids Control Programme at the Ministry of Health, in an interview with this publication yesterday, expressed strong optimism about the breakthrough.

"The picture looks bright, and very soon, I believe Ugandans will al...